Don't Eat the Marshmallow! 4 Tips for Financial Self-Control
Break's Over, Santa: Ticketmaster Kicks Off Christmas Season in May
Consumer Spending Forecast to Boost U.S. Economy
GM Shares Top Level Not Seen Since 2011
NASDAQ: VPHM
Top New Biotech Ideas from PropThink
Halozyme Therapeutics Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Viropharma's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
ViroPharma To Participate In Two May Healthcare Investor Conferences
Despite Poor Quarter, ViroPharma's Commercial And Pipeline Progress Continue
ViroPharma Management Discusses Q1 2013 Results - Earnings Call Transcript
ViroPharma Announces First Quarter 2013 Financial Results
ViroPharma sees FY13 worldwide net product sales $440M-$465M, consensus $462.67M
ViroPharma reports Q1 adjusted EPS 26c, consensus 4c